Global infection control market to reach $22.6B by 2022: 5 key trends

The global infection control market is expected to grow due to an increase in aging population, hospital-acquired infections and number of surgeries performed, according to IQ4I Research & Consultancy.

Advertisement

Here are five trends:

1. The market is expected to be valued at $22.6 billion by 2022.

2. The hospital segment was the largest in 2015 and is expected to grow the fastest through 2022.

3. North America was the largest market region-wise in 2015, with a market share of 39.5 percent.

4. The Asia region is expected to be the fastest growing region from 2015 to 2022.

5. Major players in the market include St. Paul, Minn.-based 3M Company; Göteborg, Sweden-based Getinge Group; and Alpharetta, Ga.-based Halyard Health.

More articles on healthcare quality:
10 top patient safety issues for 2017
New sepsis treatment guidelines: 5 things to know
Sepsis causes more readmissions than COPD, heart failure, heart attack and pneumonia

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.